SCHEMBL20449049

SCHEMBL20449049

CCN(CC)CCNC(=O)c1ccc(NC(=O)c2cccc(C(=O)Nc3ccc(C(=O)NCCN(CC)CC)cc3)c2)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.79
▸ KMT2A Q03164 2/20 0.76
▸ MEN1 O00255 1/20 0.76
▸ POLB P06746 2/20 0.74
▸ ALDH1A1 P00352 2/20 0.71
▸ NFKB1 P19838 1/20 0.71
▸ KCNH2 Q12809 1/20 0.71
▸ BLM P54132 2/20 0.70
▸ CYP3A4 P08684 1/20 0.70
▸ THRB P10828 1/20 0.70
▸ ATM Q13315 1/20 0.70
▸ SMN1; SMN2 Q16637 1/20 0.70
▸ MAPT P10636 2/20 0.65
▸ KDM4E B2RXH2 1/20 0.65
▸ NAMPT P43490 1/20 0.64
▸ L3MBTL1 Q9Y468 1/20 0.63
▸ MCHR1 Q99705 4/20 0.62
▸ LMNA P02545 2/20 0.60
▸ SLC22A2 O15244 1/20 0.60
▸ SLC22A1 O15245 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1499569 0.92 TDP1 (0.92) TDP1KMT2AMEN1POLBALDH1A1
SCHEMBL5583042 0.86 TDP1 (0.81) TDP1KMT2AMEN1POLBALDH1A1
SCHEMBL14831012 0.83 ALDH1A1 (0.79) TDP1KMT2AMEN1POLBALDH1A1
Acecainide SCHEMBL156943 0.83 ALDH1A1 (1.00) TDP1KMT2AMEN1POLBALDH1A1
SCHEMBL12766989 0.83 POLB (0.73) TDP1KMT2AMEN1POLBALDH1A1
Acecainide SCHEMBL122991 0.82 POLB (1.00) TDP1KMT2AMEN1POLBALDH1A1
SCHEMBL1230694 0.82 ALDH1A1 (0.77) TDP1KMT2AMEN1POLBALDH1A1
SCHEMBL542239 0.81 TDP1 (0.74) TDP1KMT2AMEN1POLBALDH1A1
Acecainide SCHEMBL1650222 0.81 ALDH1A1 (0.94) TDP1KMT2AMEN1POLBALDH1A1
SCHEMBL19354778 0.81 NPC1 (0.59) TDP1KMT2AMEN1POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10619028-B2 Polyarylene fiber with improved hydrolytic stability TEIJIN ARAMID B.V. (NL) 2020-04-14 — — US disclosed
EP-3356585-B1 POLYARYLENE FIBER WITH IMPROVED HYDROLYTIC STABILITY TEIJIN ARAMID BV (NL) 2019-05-15 — — EP disclosed
US-20180223077-A1 POLYARYLENE FIBER WITH IMPROVED HYDROLYTIC STABILITY TEIJIN ARAMID B.V. (NL) 2018-08-09 — — US disclosed
EP-3356585-A1 POLYARYLENE FIBER WITH IMPROVED HYDROLYTIC STABILITY Teijin Aramid B.V. (NL) 2018-08-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10619028-B2 Polyarylene fiber with improved hydrolytic stability PAH, COMT, MAOB TDP1 96/4885KMT2A 2022/4885MEN1 4105/4885
US-20180223077-A1 POLYARYLENE FIBER WITH IMPROVED HYDROLYTIC STABILITY PAH, COMT, DBH TDP1 94/4885KMT2A 2313/4885MEN1 4226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback